Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorNorthwestern University

About this trial

This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.

Eligibility criteria

Qualifiers

All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without urinary frequency more than 8 times daily or nocturia, with or without urgency urinary incontinence) at their index visit, who are also willing to use a dietary supplement and not initiate additional behavioral, medication or procedural treatment for 12 weeks following pumpkin seed oil extract initiation.

Disqualifiers

Use of other supplements that contain pumpkin seed oil

≥Stage 3 pelvic organ prolapse

Urinary post-void residual ≥150cc

Culture-proven urinary tract infection at time of study enrollment

Trial design

Treatments tested in this trial

  • Pumpkin Seed Extract

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators